--- title: Official Best of San Antonio Breast Cancer Symposium® News – Highlights 2021 description: Registration for the Official Best of SABCS® News Highlights is now available. image: https://news.lifesciencenewswire.com/hubfs/BoSABCS_NEWS_logo%20-%201200.png --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (34)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (20)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (15)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (244)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (9)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (108)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (283)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Drug Discovery & Development (147)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (55)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (132)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (6)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (25)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (86)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (114)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (4)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (5)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates - ##### SHARE - - - # [Official Best of San Antonio Breast Cancer Symposium® News – Highlights 2021](https://news.lifesciencenewswire.com/newsroom/official-best-of-san-antonio-breast-cancer-symposium-news-highlights-2021) December 6, 2021 *Subscribe Now -Highlights of the Foremost meeting in breast cancer research in the world.* *December 6-10, 2021* ![BoSABCS_NEWS_logo - 1200](https://news.lifesciencenewswire.com/hs-fs/hubfs/BoSABCS_NEWS_logo%20-%201200.png?width=351&name=BoSABCS_NEWS_logo%20-%201200.png)Registration for the Official Best of SABCS® News Highlights is now available at [www.bestofsabcsnews.com](http://www.bestofsabcsnews.com). The Best of SABCS® News Highlights ([www.bestofsabcsnews.com](http://www.bestofsabcsnews.com/)) provides Original Presentation Slides, presented with key analysis by world-renowned experts including Drs. Virginia Kaklamani, Hope Rugo, William Gradishar, Adam Brufsky, Ruth O’Regan, Joseph Sparano, among others The Best of SABCS NEWS HIGHLIGHTS will be available in both ENGLISH and SPANISH. [https://youtu.be/E-elALIc6CU](https://youtu.be/E-elALIc6CU) The first Highlights will be published on December 8, 2021 at 4:00 pm CDT (GMT -6 hours), and every day thereafter, will cover key advances presented in: Translational Medicine; Imaging/Local Therapy; Hormonal Receptor Positive, Triple Negative, and HER2 Positive Trials, Novel Agents, and Survivorship/Lifestyle. HIGHLIGHTS will include research on: TRANSLATIONAL MEDICINE - NeoTRIPaPDL1 Trial - SAFIR02-BREAST - cTRAK TN Trial - An Analysis of TBCRC 038 and RAHBT Cohorts - BioltaLEE Trial HORMONE RECEPTOR POSITIVE: - Final Results from Phase 3 PALLAS Trial - Results of EMERALD Phase 3 Trial - Correlative analysis of overall survival across MONOLEESA -2, -3, and -7 - Results of SWOG S8814 Trial - Final efficacy, safety, and biomarker results from TRINITI – 1 TRIPLE NEGATIVE: - KEYNOTE-522 and KEYNOTE-355 study results - PEARL Trial updates - AZTEC Phase 2 trial - BEGONIA: A Phase 1b/2 study HER2 POSITIVE: - Phase 3 study of DESTINY-Breast 03 - Latest Update from the SUMMIT Trial - DEBBRAH Phase 2 Study - Phase 3 SOPHIA study - DAISY Phase 2 study with biomarkers analysis - Final Results from SOLTI-1303 PATRICIA - IMpassion131 Trial Novel Agents: - Phase 1 TROPION-Pan Tumor 01 Study - Nimbus: Phase 2 trial of nivolumab plus ipilimumab - Study of samuraciclib (CT7001) a first in class, oral, selective inhibitor of CDK7 in combination with fulvestrant - FORTRESS, an international, randomized, Phase 3 trial - SOLTI-1805 TOT- HER 3 - Primary analysis of the randomized, open-label, phase 2 coopERA breast cancer study About Best of SABCS® programs The San Antonio Breast Cancer Symposium®, now in its 44th year, is the premier conference for basic, translational, and clinical cancer research professionals. It is well-known for presenting the latest breast cancer data from all over the world. Best of SABCS® programs offer professionals the opportunity to experience and discuss the most current research and advances in the field of breast cancer with colleagues and key opinion leaders with access to the original presentations and posters. For information on Best of SABCS® opportunities, please visit [www.bestofsabcs.com.](http://www.bestofsabcs.com) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) ##### Browse more news ## Recent releases #### [Enhanced Compliance Inc. (ECI) Appoints Taranjit S. Samra as Head of Medical Device Software Enginee...](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) July 6, 2026 Strengthens ECI’s AI & Digital Transformation capabilities to help clients develop the next generation of software-enabled medical technologies En... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomic...](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) #### [Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) June 16, 2026 Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)